Acetyl Tetrapeptide-3 is a synthetic tetrapeptide used in cosmetic formulas that take a structural, scalp-focused approach to hair care. Much of the evidence commonly cited for this peptide comes from extracellular-matrix (ECM) research, fibroblast studies and combination formulas that also contain red clover extract. It should therefore not be presented as a proven stand-alone treatment for hair loss or as an ingredient proven to grow new hair.
This guide separates the evidence for the peptide itself from evidence for branded combination ingredients, explains its actual relationship with Capixyl, and clarifies why collagen XVII should not be attributed directly to Acetyl Tetrapeptide-3.
What Is Acetyl Tetrapeptide-3?
Acetyl Tetrapeptide-3 is a four-amino-acid synthetic peptide used in cosmetic formulations. Current literature describes it as Ac-KGHK; PubChem lists the KGHK sequence, corresponding to Lys-Gly-His-Lys.
The word “acetyl” refers to its acetylated structure and “tetrapeptide” refers to its four amino acids. Claims that acetylation of this particular peptide has been clinically proven to enhance penetration through cell membranes or into the human hair follicle go beyond the available direct human evidence.
Why Does the Extracellular Matrix Matter?
The hair follicle interacts continuously with surrounding cells and the extracellular matrix. Collagens, laminins and other matrix proteins provide structural support and also contribute to biological signaling within the local microenvironment.
This is why peptides that influence ECM proteins are studied in structural cosmetic-care approaches. However, an increase in a matrix protein in a laboratory model does not by itself prove less hair shedding or greater hair growth in people.
What Does Research Show for Acetyl Tetrapeptide-3?
A 2026 review of short peptides used in hair-loss research summarizes the available mechanistic data for Acetyl Tetrapeptide-3. The preclinical studies cited in that review report increased collagen III and laminin production in human fibroblasts and increased collagen VII expression in human skin explants.
These findings help explain why the peptide is used in ECM-focused cosmetic formulas. Most of this evidence, however, comes from cell culture, skin-explant or raw-material/combination studies. Strong, independent, large-scale human evidence showing that Acetyl Tetrapeptide-3 alone reduces hair loss or produces new hair remains limited.
Collagen XVII Matters — But It Is a Separate Evidence Line
Collagen XVII (COL17A1/BP180) is genuinely important to the maintenance of the hair-follicle stem-cell niche. A 2016 study in Science showed that COL17A1 proteolysis is involved in hair-follicle stem-cell aging and follicle miniaturization.
That finding does not establish that Acetyl Tetrapeptide-3 increases collagen XVII. The structural-protein findings reported directly for Acetyl Tetrapeptide-3 concern mainly collagen III, collagen VII and laminin. The two evidence streams should not be merged.
What Is Capixyl?
Capixyl is a commercial cosmetic raw-material complex that combines Acetyl Tetrapeptide-3 with red clover (Trifolium pratense) extract. Red clover is associated with isoflavones such as biochanin A. Some of the human data frequently discussed around Acetyl Tetrapeptide-3 were generated with this combination rather than with the peptide alone.
The current Mirissa Lab Scalp Serum ingredient list contains both Acetyl Tetrapeptide-3 and Trifolium Pratense Flower Extract. An INCI list alone, however, does not prove that a specific branded Capixyl raw material is used or that it is present at a supplier-standardized concentration. That requires manufacturing and raw-material documentation.
Is It the Same as Biotinoyl Tripeptide-1?
No. Biotinoyl Tripeptide-1 is a different peptide. The current Mirissa Lab serum formula also includes Biotinoyl Tripeptide-1 together with Apigenin and Oleanolic Acid. These ingredients should not be described as the same active or the same commercial complex as Acetyl Tetrapeptide-3.
The key correction is simple: Acetyl Tetrapeptide-3 + Biotinoyl Tripeptide-1 is not Capixyl. Capixyl is characterized by Acetyl Tetrapeptide-3 together with red clover extract.
Why Is It Included in Mirissa Lab Scalp Serum?
Mirissa Lab Scalp Serum is not built around a single active. Acetyl Tetrapeptide-3 appears alongside Biotinoyl Tripeptide-1, Apigenin, Oleanolic Acid, Niacinamide, Zinc PCA, Panthenol, Squalane and other care ingredients.
A defensible cosmetic role for Acetyl Tetrapeptide-3 in this formula is as one part of a multi-active architecture focused on structural scalp care and the appearance of stronger, fuller-looking hair. A specific percentage reduction in shedding, guaranteed new-hair growth or another definitive clinical result cannot be inferred merely from the ingredient being present.
Explore Mirissa Lab Scalp Serum →
Who May Include It in a Cosmetic Routine?
Scalp serums containing Acetyl Tetrapeptide-3 may appeal to people who feel that their hair looks thinner, weaker or prone to shedding and who want a consistent scalp-focused cosmetic routine.
Sudden, marked, patchy or progressive hair loss, or scalp symptoms such as sores, significant redness or persistent itching, require medical assessment. Cosmetic care does not replace dermatological evaluation for suspected androgenetic alopecia or other hair-loss disorders.
How Should Mirissa Lab Scalp Serum Be Used?
According to the current product directions, apply the serum at night to a clean, dry or slightly damp scalp. Part the hair, apply the product directly to the scalp, massage gently with the fingertips and leave it in without rinsing.
For a consistent care routine, it can be used several nights per week. Claims such as “application immediately after showering maximizes absorption” or “a two-to-three-minute massage is required” should not be stated as proven advantages without finished-product evidence.
How Long Does It Take to See Results?
There is no universal timeline stating that Acetyl Tetrapeptide-3 produces one effect at four to six weeks and another at eight to twelve weeks. Results depend on the complete formula, consistency of use, individual scalp and hair characteristics, and the outcome being measured.
Any exact week or percentage claim for a Mirissa Lab product should be based on adequate clinical evidence generated on that finished product and the relevant endpoint. A guaranteed timeline should not be inferred from raw-material data.
Safety and CosIng
The European Commission’s CosIng resource is an informational cosmetic-ingredient and nomenclature database. The Commission explicitly states that appearance of an INCI name in CosIng does not itself mean that an ingredient is approved for cosmetic use, safe at every concentration or granted a special unrestricted-use status.
Cosmetic safety must be assessed in the context of the complete finished formula, exposure, intended area of use and applicable regulation.
Frequently Asked Questions
What does Acetyl Tetrapeptide-3 do?
Preclinical research has reported effects involving collagen III, collagen VII and laminin. These findings provide a rationale for structural scalp-care positioning, but they do not prove that the peptide alone treats hair loss or grows new hair.
Does Acetyl Tetrapeptide-3 increase collagen XVII?
Collagen XVII is important to the hair-follicle stem-cell niche, but robust direct evidence that Acetyl Tetrapeptide-3 increases collagen XVII has not been established. The peptide’s reported ECM findings concern mainly collagen III, collagen VII and laminin.
What is Capixyl?
Capixyl is a commercial complex combining Acetyl Tetrapeptide-3 with red clover (Trifolium pratense) extract. Acetyl Tetrapeptide-3 combined with Biotinoyl Tripeptide-1 is not Capixyl.
Does Mirissa Lab Scalp Serum contain Acetyl Tetrapeptide-3?
Yes. The current product ingredient list includes Acetyl Tetrapeptide-3. It also contains Trifolium Pratense Flower Extract and, separately, Biotinoyl Tripeptide-1, Apigenin and Oleanolic Acid.
Does it prevent age-related hair thinning?
That is not established as a stand-alone prevention claim for this peptide. Collagen XVII is biologically linked to follicle aging, but that does not prove that Acetyl Tetrapeptide-3 prevents age-related hair loss through collagen XVII.
How quickly does it work?
There is no single standard timeline. Exact week or percentage claims should come from clinical data on the finished product being discussed.
Does a CosIng listing prove safety?
No. CosIng is an informational and nomenclature database, not an automatic safety approval or authorization. Safety is assessed at finished-product level.
Scientific References
- Overview of Short Peptides for Hair Loss. Biomedicines. 2026;14(4):864. PMID: 42072405.
- Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science. 2016;351(6273):aad4395. PMID: 26912707.
- European Commission. CosIng – Cosmetic ingredient database / Glossary of ingredients.
This content is for informational purposes. Mirissa Lab products are cosmetic care products and do not replace medical diagnosis or treatment.
